Health Industry Manufacturers Association (HIMA) predicts US medical technology drain
This article was originally published in Clinica
Executive Summary
Public policies - especially the FDA device approval process - combined with market forces have set off a chain reaction that is sapping the vigour of the US medical technology industry. This could signal the end of US innovation leadership in this field, claims a study commissioned by the US Health Industry Manufacturers Association entitled Forces Reshaping the Performance and Contribution of the US Medical Device Industry.